Fluorescent Enzyme Immunoassay

Fluorescent enzyme immunoassay (FEIA) is an analytical method that combines the selective binding of antibodies to target molecules with enzyme-generated fluorescence, enabling sensitive detection and quantification in biological samples. In a typical assay, an antigen or antibody is immobilized or captured, an enzyme-labeled immune reagent binds the target, and addition of a fluorogenic substrate produces light; fluorescence intensity reflects the amount of analyte present. FEIA supports measurement of hormones, antibodies, proteins, pathogens, and other biomarkers in clinical and research settings, providing a reproducible alternative to assays based on color or radioactivity and helping characterize immune responses and disease-associated changes.

Fluorescent Enzyme Immunoassay - Related Videos

Research

JoVE EoE - Immunodiagnostics

Reporter Enzyme Fluorescence Imaging for In Vivo Tracking of Bacterial Infection

0 Views •

2025

This video demonstrates the reporter enzyme fluorescence (REF) imaging for in vivo detection of Mycobacterium tuberculosis infection. The infected mice are intraperitoneally injected with a substrate for REF imaging. Upon being hydrolyzed by bacterial β-lactamase enzyme, the substrate emits fluorescence, the detection of which aids evaluation of infection.

Research

JoVE Journal - Biology
Free Sample

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

0 Views •

Cited by 19 •

2011

Using Luminex Corporation’s xMAP microsphere technology, we have developed the Multiplexed Fluorometric ImmunoAssay (MFIA) for serosurveillance of various laboratory animal species. The MFIA is a suspension microarray where antigen, tissue control or immunoglobulins are covalently linked to color-coded polystyrene microspheres. The MFIA testing method as well as various troubleshooting topics is addressed.

A Capillary Electrophoresis Immunoassay for Protein Biomarker Detection

0 Views •

2025

This video demonstrates a capillary electrophoresis immunoassay protocol for detecting a protein biomarker associated with amyotrophic lateral sclerosis (ALS) from human blood platelets. Confirmation of the presence of the ALS biomarker protein is achieved through size-based separation of the platelet proteins followed by chemiluminescent detection.

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

0 Views •

Cited by 3 •

2017

We demonstrate a snap chip technology for performing cross-reactivity-free multiplexed sandwich immunoassays by simply snapping two slides. A snap apparatus is used for reliably transferring reagents from microarray-to-microarray. The snap chip can be used for any biochemical reactions requiring colocalization of different reagents without cross-contamination.

Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform

0 Views •

Cited by 4 •

2016

Nanoparticle-based optical probes have been designed as a vehicle for detecting antigens using Raman and UV-Vis spectroscopy. Here we describe a protocol for preparing such probes for a UV-Vis/Raman spectroscopy immunoassay in such a way to incorporate future multiplexing capabilities.

View All Results

FAQs

Related Topics